0001567619-19-018220.txt : 20190912 0001567619-19-018220.hdr.sgml : 20190912 20190912200438 ACCESSION NUMBER: 0001567619-19-018220 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190910 FILED AS OF DATE: 20190912 DATE AS OF CHANGE: 20190912 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Krainer Adrian R. CENTRAL INDEX KEY: 0001780081 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38938 FILM NUMBER: 191091376 MAIL ADDRESS: STREET 1: C/O STOKE THERAPEUTICS, INC. STREET 2: 45 WIGGINS AVE CITY: BEDFORD STATE: MA ZIP: 01730 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Stoke Therapeutics, Inc. CENTRAL INDEX KEY: 0001623526 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 471144582 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3 PRESTON COURT CITY: BEDFORD STATE: MA ZIP: 01730 BUSINESS PHONE: 781-430-8200 MAIL ADDRESS: STREET 1: 3 PRESTON COURT CITY: BEDFORD STATE: MA ZIP: 01730 FORMER COMPANY: FORMER CONFORMED NAME: ASOthera Pharmaceuticals, Inc. DATE OF NAME CHANGE: 20141028 4 1 doc1.xml FORM 4 X0306 4 2019-09-10 0 0001623526 Stoke Therapeutics, Inc. STOK 0001780081 Krainer Adrian R. C/O STOKE THERAPEUTICS, INC. 45 WIGGINS AVENUE BEDFORD MA 01730 1 0 0 0 Director Stock Option (Right to Buy) 28.80 2019-09-10 4 A 0 14777 0 A 2029-09-09 Common Stock 14777 14777 D This option vests 100% and becomes exercisable on June 21, 2020, subject to reporting person's continued service through such vesting date. /s/Stephen Tulipano, Attorney-in-Fact 2019-09-12